• 1
    Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 1536.
  • 2
    Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2000: cancer incidence, mortality and prevalence worldwide. version 1.0. IARC Cancer Base No. 5. Lyon: IARC, 2001.
  • 3
    Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK,1979-94. Lancet 1997; 350: 11423.
  • 4
    Deuffic S, Poynard T, Buffat L, Valleron AJ. Trends in primary liver cancer. Lancet 1998; 351: 2145.
  • 5
    El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999; 340: 74550.
  • 6
    IARC. Monographs on evaluation of carcinogenic risks to humans. Hepatitis viruses. vol. 59. Lyon: IARC, 1994.
  • 7
    Pisani P, Parkin DM, Munoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387400.
  • 8
    IARC. Monographs on evaluation of carcinogenic risks to humans. Alcohol drinking. vol. 44. Lyon: IARC, 1998.
  • 9
    World Cancer Research Fund. Food, nutrition and the prevention of cancer: a global perspective. Liver. Washington, DC: American Institute for Cancer Research, 1997. p 20214.
  • 10
    IARC. Monographs on evaluation of carcinogenic risks to humans. Tobacco smoking and involuntary smoking. vol. 83. Lyon: IARC, 2002.
  • 11
    Tanaka T, Nishikawa A, Shima H, Sugie S, Shinoda T, Yoshimi N, Iwata H, Mori H. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 1990; 52: 42940.
  • 12
    Casiglia E, Spolaore P, Ginocchio G, Ambrosio GB. Unexpected effects of coffee consumption on liver enzymes. Eur J Epidemiol 1993; 9: 2937.
  • 13
    Kono S, Shinchi K, Imanishi K, Todoroki I, Hatsuse K. Coffee and serum gamma-glutamyltransferase: a study of self-defense officials in Japan. Am J Epidemiol 1994; 139: 7237.
  • 14
    Tanaka K, Tokunaga S, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998; 27: 43843.
  • 15
    Honjo S, Kono S, Coleman MP, Shinchi K, Sakurai Y, Todoroki I, Umeda T, Wakabayashi K, Imanishi K, Nishikawa H, Ogawa S, Katsurada M, et al. Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001; 54: 8239.
  • 16
    Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992; 136: 124857.
  • 17
    Corrao G, Zambon A, Bagnardi V, D'Amicis A, Klatsky A. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001; 11: 45865.
  • 18
    La Vecchia C, Ferraroni M, Negri E, D'Avanzo B, Decarli A, Levi F, Franceschi S. Coffee consumption and digestive tract cancers. Cancer Res 1989; 49: 104951.
  • 19
    Kuper H, Tzonou A, Kaklamani E, Hsieh CC, Lagiou P, Adami HO, Trichopoulos D, Stuver SO. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer 2000; 85: 498502.
  • 20
    Gallus S, Bertuzzi M, Tavani A, Bosetti C, Negri E, La Vecchia C, Lagiou P, Trichopoulos D. Does coffee protect against hepatocellular carcinoma? Br J Cancer 2002; 87: 9569.
  • 21
    Fukao A, Tsubono Y, Komatsu S, Tsuji I, Minami Y, Hisamichi S, Hosokawa T, Kawamura M, Takao A, Sugahara N, Ikeda T, Nishikori M. A cohort study on the relation of lifestyle, personality and biologic markers to cancer in Miyagi, Japan: study design, response rate and profiles of the cohort subjects. J Epidemiol 1995; 5: 15357.
  • 22
    Tsubono Y, Nishino Y, Komatsu S, Hsieh CC, Kanemura S, Tsuji I, Nakatsuka H, Fukao A, Satoh H, Hisamichi S. Green tea and the risk of gastric cancer in Japan. N Engl J Med 2001; 344: 6326.
  • 23
    Nakaya N, Tsubono Y, Hosokawa T, Nishino Y, Ohkubo T, Hozawa A, Shibuya D, Fukudo S, Fukao A, Tsuji I, Hisamichi S. Personality and the risk of cancer. J Natl Cancer Inst 2003; 95: 799805.
  • 24
    PercyC, Van HoltenV, MuirC International classification of diseases for oncology, 2nd ed. Geneva: WHO, 1990.
  • 25
    Takano A, Okuno Y. Japan, Miyagi Prefecture. In: ParkinDM, WhelanSL, FerlayJ, RaymondL, YoungJ, eds. Cancer incidence in five continents. International Agency for Research on Cancer, vol. 7. Lyon: IARC, 1997. p 38689.
  • 26
    Petitti DB. Statistical methods in meta-analysis. In: meta-analysis, decision analysis, and cost-effectiveness analysis: methods for quantitative synthesis in medicine. New York: Oxford University Press, 1994.p 90114.
  • 27
    La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev 1998; 7: 31520.
  • 28
    Takahashi H, Seo T, Kawamura S. Study on the result of hepatitis virus test for essential health check. Yobou Igaku J 2003; 388: 3236.
  • 29
    All Japan Coffee Association. A basic survey for monitoring trends in the demand for coffee. Tokyo: All Japan Coffee Association, 2003.
  • 30
    Nehlig A, Debry G. Potential genotoxic, mutagenic and antimutagenic effects of coffee: a review. Mutat Res 1994; 317: 14562.
  • 31
    Resources Council, Science and Technology Agency, Japan. Standard tables of food composition in Japan, 5th ed. Tokyo: Printing Bureau, Ministry of Finance, 2000.
  • 32
    Cavin C, Holzhaeuser D, Scharf G, Constable A, Huber WW, Schilter B. Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity. Food Chem Toxicol 2002; 40: 115563.
  • 33
    Urgert R, van der Weg G, Kosmeijer-Schuil TG, van de Bovenkamp P, Hovenier R, Katan MB. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995; 43: 216772.